ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,407 Cr | ₹1,343 Cr | ₹1,206 Cr | ₹1,203 Cr | ₹1,031 Cr |
What is the latest Total Current Liabilities ratio of ABBOTT INDIA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,407 Cr |
| Mar2024 | ₹1,343 Cr |
| Mar2023 | ₹1,206 Cr |
| Mar2022 | ₹1,203 Cr |
| Mar2021 | ₹1,031 Cr |
How is Total Current Liabilities of ABBOTT INDIA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,407 Cr | 4.80 | |
| Mar2024 | ₹1,343 Cr | 11.33 | |
| Mar2023 | ₹1,206 Cr | 0.24 | |
| Mar2022 | ₹1,203 Cr | 16.72 | |
| Mar2021 | ₹1,031 Cr | - | |
Compare Total Current Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹59,107.7 Cr | 2.8% | 6.9% | -19.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 2.8% |
6.9% |
-19.6% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses